Tandem Diabetes Care | TNDM - 税前利润



金融业
股票价格
USD
资产
USD 1.15B
现金及等价物
USD 179.33M
销售成本
USD 122.92M
流动资产
USD 887.1M
流动负债
USD 247.96M
债务
USD 444.48M
EBIT
USD 8.29M
EBITDA
USD 2.73M
员工
2.65K
EPS每股收益
USD -0.3
股本和储备
USD 132.4M
销售毛利
USD 167.46M
债务利息支出
USD 1.15B
利息收入
USD 3.02M
贷款资金
USD 601.77M
市值
USD 1.03B
净收入
USD -589K
营业费用
USD 282.09M
营业利润
USD 8.29M
普通股股本
USD 68.29M
PE价格收益
681.05
税前利润
USD 4.68M
销售收入
USD 247.22M
销售和管理费用
USD 99.86M
股票
USD 126.4M
贸易债权人
USD 59.86M
应收帐款人
USD 165.49M


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 394K 1.97M 2026-03
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Eli Lilly USD 8.27B 1.03B 2025-12
Globus Medical USD 169.23M 25.24M 2025-12
ICU Medical USD -15.9M 86.2M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 71.3M 3.6M 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Orthofix International USD -2.19M 20.07M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12